Drug Type TCR-T Cell therapy |
Synonyms SA 302, SA-302, SA302 |
Target |
Action modulators |
Mechanism KRAS modulators(GTPase KRas modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colorectal Cancer | Preclinical | China | 01 Oct 2024 | |
| Lung Cancer | Preclinical | China | 01 Oct 2024 | |
| Pancreatic Cancer | Preclinical | China | 01 Oct 2024 |





